ARCHIVES

Ibrutinib Produces 68% Overall Response Rate in Phase II Trial

This article is from The Cancer Letter archive.

Vol. 36 No. 1 | January 25, 2013

Download PDF Visit The Full Archive

Related Articles

First Formal CREG Guidelines, Rules Publishes

June 6, 1975

NIH Advisors Suggest Revamping Grant Application Review

June 14, 1996

In Brief: Salmon To Step Down As Center Director; Becker To Relinquish Positions At MDACC

September 4, 1998

HHS Secretary Tommy Thompson announced his resignation.

December 3, 2004

Eppley Probe Could Lead to Tighter Reporting By NIH supported Investigators

June 17, 1977

Cancer Genetics Network approved By NCI Advisors, To Start With 8 Centers

November 29, 1996